Mason Hawkins's ABT Position Overview
Mason Hawkins (via Southeastern Asset Management Inc/Tn/) currently holds 840,747 shares of Abbott Laboratories (ABT) worth $76.29 M, representing 3.98% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Mason Hawkins has maintained a strategic position in ABT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 840,747 shares. Largest reduction occurred in Q1 2015, reducing 8.98 M shares.
Analysis based on 13F filings available since 2013 Q2
Mason Hawkins's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Mason Hawkins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +840,747 | New Buy | 840,747 | $90.74 |
| Q1 2015 | -8.98 M | Sold Out | 0 | $0.00 |
| Q4 2014 | -3.51 M | Reduce 28.08% | 8.98 M | $45.02 |
| Q3 2014 | -1.2 M | Reduce 8.80% | 12.48 M | $41.59 |
| Q2 2014 | -59,467 | Reduce 0.43% | 13.69 M | $40.90 |
| Q1 2014 | +302,000 | Add 2.25% | 13.75 M | $38.51 |
| Q4 2013 | -282,512 | Reduce 2.06% | 13.45 M | $38.33 |
| Q3 2013 | -690,449 | Reduce 4.79% | 13.73 M | $33.19 |
| Q2 2013 | +14.42 M | Add 0.00% | 14.42 M | $34.88 |
Mason Hawkins's Abbott Laboratories Investment FAQs
Mason Hawkins first purchased Abbott Laboratories (ABT) in Q2 2013, acquiring 14,418,305 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mason Hawkins has held Abbott Laboratories (ABT) for 9 quarters since Q2 2013.
Mason Hawkins's largest addition to Abbott Laboratories (ABT) was in Q2 2013, adding 14,418,305 shares worth $502.91 M.
According to the latest 13F filing for Q2 2026, Mason Hawkins's firm, Southeastern Asset Management Inc/Tn/, owns 840,747 shares of Abbott Laboratories (ABT), valued at approximately $76.29 M.
As of the Q2 2026 filing, Abbott Laboratories (ABT) represents approximately 3.98% of Mason Hawkins's publicly disclosed stock portfolio, making it one of their key holdings.
Mason Hawkins's peak holding in Abbott Laboratories (ABT) was 14,418,305 shares, as reported at the end of Q2 2013.